Wendell David Associates Inc / ABT
Wendell David Associates Inc’s Abbott Laboratories Position
Does Wendell David Associates Inc own Abbott Laboratories (ABT)? Yes — 210.5K shares worth $22M (+2.35% of its 13F portfolio) as of Q1 2026, down from 211.7K shares the prior filed quarter.
Position Value
$22M
Q1 2026
Shares
210.5K
% of Portfolio
+2.35%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 210.5K | $22M | +2.35% |
| Q4 2025 | 211.7K | $27M | +2.69% |
| Q3 2025 | 218.2K | $29M | +2.89% |
| Q2 2025 | 217.8K | $30M | +2.98% |
| Q1 2025 | 220.3K | $29M | +2.92% |
| Q4 2024 | 222.2K | $25M | +2.49% |
| Q3 2024 | 223.5K | $25M | +2.44% |
| Q2 2024 | 224.4K | $23M | +2.38% |
| Q1 2024 | 226.0K | $26M | +2.60% |
| Q4 2023 | 225.2K | $25M | +2.67% |
| Q3 2023 | 224.4K | $22M | +2.56% |
| Q2 2023 | 221.5K | $24M | +2.73% |
| Q1 2023 | 222.1K | $22M | +2.67% |
| Q4 2022 | 221.6K | $24M | +2.99% |
| Q3 2022 | 221.7K | $21M | +2.89% |
| Q2 2022 | 222.0K | $24M | +3.07% |
| Q1 2022 | 214.1K | $25M | +2.82% |
| Q4 2021 | 218.4K | $31M | +3.11% |
| Q3 2021 | 219.7K | $26M | +2.89% |
| Q2 2021 | 219.8K | $25M | +2.85% |
| Q1 2021 | 213.3K | $26M | +3.08% |
| Q4 2020 | 207.3K | $23M | +2.78% |
| Q3 2020 | 208.0K | $23M | +3.02% |
| Q2 2020 | 202.2K | $18M | +2.68% |
| Q1 2020 | 189.6K | $15M | +2.53% |
| Q4 2019 | 189.4K | $16M | +2.27% |
| Q3 2019 | 190.4K | $16M | +2.33% |
| Q2 2019 | 192.0K | $16M | +2.42% |
| Q1 2019 | 194.5K | $16M | +2.42% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wendell David Associates Inc’s full portfolio or all institutional holders of ABT.